Federico Bernardini
Overview
Explore the profile of Federico Bernardini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naciu A, Nusca A, Palermo A, Piccirillo F, Tabacco G, DAmico A, et al.
J Clin Endocrinol Metab
. 2025 Mar;
PMID: 40037625
Context: Both primary hyperparathyroidism (PHPT) and chronic hypoparathyroidism (HypoPT) are associated with the onset and development of cardiovascular diseases (CVDs). However, the molecular mechanisms underlying the effects of parathyroid disorders...
2.
Figus C, Carlson K, Bortolini E, Saers J, Seghi F, Sorrentino R, et al.
Am J Biol Anthropol
. 2025 Feb;
186(2):e70007.
PMID: 39936218
Objectives: To investigate the developmental changes in the human calcaneal internal and external morphology linked to the acquisition of mature bipedal locomotion. Methods: Seventy seven micro-CT scans of modern juvenile...
3.
Nusca A, Di Bitonto M, Spano A, Federico B, Bernardini F, Mangiacapra F, et al.
Am J Cardiol
. 2025 Jan;
240:50-56.
PMID: 39805357
Contrast-associated acute kidney injury (CA-AKI) remains a serious complication after percutaneous coronary revascularization (PCI), with limited effective preventive strategies especially for diabetic patients. This study aimed to assess the effects...
4.
Bouchet F, Zanolli C, Skinner M, Urciuoli A, Fortuny J, Almecija S, et al.
J Hum Evol
. 2024 Sep;
195:103581.
PMID: 39243703
The phylogenetic relationships of the small-bodied catarrhine Pliobates cataloniae (∼11.6 Ma, NE Iberian Peninsula) have been controversial since its original description. However, the recent report of additional dentognathic remains has...
5.
Bernardini F, Nusca A, Coletti F, Porta Y, Piscione M, Vespasiano F, et al.
Pharmaceutics
. 2023 Jul;
15(7).
PMID: 37514043
Atherosclerosis is the leading cause of death worldwide, especially in patients with type 2 diabetes mellitus (T2D). GLP-1 receptor agonists and DPP-4 inhibitors were demonstrated to play a markedly protective...
6.
Zanolli C, Bouchet F, Fortuny J, Bernardini F, Tuniz C, Alba D
J Hum Evol
. 2023 Mar;
177:103326.
PMID: 36863301
A vast diversity of catarrhines primates has been uncovered in the Middle to Late Miocene (12.5-9.6 Ma) of the Vallès-Penedès Basin (northeastern Spain), including several hominid species (Pierolapithecus catalaunicus, Anoiapithecus...
7.
Nusca A, Piccirillo F, Bernardini F, De Filippis A, Coletti F, Mangiacapra F, et al.
Int J Mol Sci
. 2022 Jul;
23(13).
PMID: 35806265
Coronary artery disease (CAD) remains one of the most important causes of morbidity and mortality worldwide, and revascularization through percutaneous coronary interventions (PCI) significantly improves survival. In this setting, poor...
8.
Figus C, Stephens N, Sorrentino R, Bortolini E, Arrighi S, Higgins O, et al.
Anat Rec (Hoboken)
. 2022 Jun;
306(1):124-142.
PMID: 35656925
Objective: The development of bipedalism is a very complex activity that contributes to shaping the anatomy of the foot. The talus, which starts ossifying in utero, may account for the...
9.
Chimenti C, Magnocavallo M, Ballatore F, Bernardini F, Alfarano M, Della Rocca D, et al.
Card Electrophysiol Clin
. 2022 Feb;
14(1):53-62.
PMID: 35221085
The clinical manifestations of COVID-19 are widely variable and may involve several districts. Although the clinical course is mostly characterized by respiratory involvement, up to 30% of hospitalized patients have...
10.
Nusca A, Bernardini F, Mangiacapra F, Maddaloni E, Melfi R, Ricottini E, et al.
J Diabetes Res
. 2022 Jan;
2021:4952447.
PMID: 35005029
Background: Ranolazine is a second-line drug for the management of chronic coronary syndromes (CCS). Glucose-lowering and endothelial effects have also been reported with this agent. However, whether ranolazine may improve...